Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing of murine ESC-derived cardiac progenitor cells treated with screening hit compound Cucurbitacin I Hydrate

ABSTRACT: RNA sequencing of murine ESC-derived cardiac progenitor cells treated with screening hit compound Cucurbitacin I Hydrate

PROVIDER: PRJNA528273 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8756993.fastq.gz	Fastqsanger.gz
	SRR8756994.fastq.gz	Fastqsanger.gz
	SRR8756995.fastq.gz	Fastqsanger.gz
	SRR8756996.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

RNA sequencing of murine ESC-derived cardiac progenitor cells treated with screening hit compound Cucurbitacin I Hydrate

Project description:Cucurbitacin I Hydrate promotes selection towards atrial cardiac fate when cardiac progenitor cells are treated with the compound. RNA sequencing was performed to assess transcript expression of signaling pathways or regulators of atrial or ventricular cardiac differentiation.

2023-03-17 | GSE128609 | GEO

RNA sequencing of murine C2C12 cell treated with high-throughput screening hit compound 6,8-dimethyl-3-(4-phenyl-1H-imidazol-5-yl)quinolin-2(1H)-one.

Project description:The hit compound promotes expression and acitivity of alkaline phosphatase in murine cells that are bipotential for myogenic and osteoblastogenic differentiaion. RNA sequecing was performed to assess global transcript expression, with particular attention to genes indicative of osteoblast and bone differentiation.

2020-01-15 | GSE125052 | GEO

Natural compound screening

Project description:Transcriptional expression data for bioactive small molecules for mechanism identification. Keywords: Expression profiling by array MCF7 cells were treated with either NSC76022 (thaspine) or DMSO control for six hours, to identify compound specific gene regulation.

2009-10-04 | E-GEOD-13124 | biostudies-arrayexpress

Small Polar Hits against S. aureus: Screening, Initial Hit Optimization, and Metabolomic Studies

Project description:The global prevalence of antibacterial resistance requires new antibacterial drugs with novel chemical scaffolds and modes of action. It is also vital to design compounds with optimal physicochemical properties to permeate the bacterial cell envelope. We described an approach of combining and integrating whole cell screening and metabolomics into early antibacterial drug discovery using a library of small polar compounds. Whole cell screening of a diverse library of small polar compounds against Staphylococcus aureus gave compound 2. Hit expansion was carried out to determine structure-activity relationships. A selection of compounds from this series, together with other screened active compounds, was subjected to an initial metabolomics study to provide a metabolic fingerprint of the mode of action. It was found that compound 2 and its analogues have a different mode of action from some of the known antibacterial compounds tested. This early study highlighted the potential of whole cell screening and metabolomics in early antibacterial drug discovery. Future works will require improving potency and performing orthogonal studies to confirm the modes of action.

2021-11-04 | MTBLS788 | MetaboLights

Full transcriptome analysis of MCF-7 cells treated with screening hit compounds versus control

Project description:This experiment was performed as part of a hit screening project. Transcriptome analysis was performed to determine whether the screened hits induced a gene expression pattern consistent with proteasome inhibition. MCF-7 cells were exposed to 2x[IC50] of hit compounds for six hours. RNA was processed according to manufacturer's protocol for preparation of HuGene 2.0ST chips to acquire biotinylated sense-strand DNA. Biotinylated DNA was hybridized to HuGene 2.0ST chips at 37°C for 16 hours in a GeneChip® Hybridization Oven 645, washed and stained using the GeneChip® Fluidics Station 450 using the FS450_0002 protocol and scanned with a GeneChip® Scanner 3000 7G.

2018-08-04 | E-MTAB-7024 | biostudies-arrayexpress

Dynamic lncRNA expression pattern during ESC-derived cardiac differentiation

Project description:Long noncoding RNAs (lncRNAs) have emerged as crucial regulators of gene expression during embryonic stem cell (ESC) self-renewal and differentiation. Here, we systemically analyzed the differentially regulated lncRNAs during ESC-derived cardiomyocyte (CM) differentiation. We established a perspicuous profile of lncRNA expression at four critical developmental stages and found that the differentially expressed lncRNAs were grouped into six distinct clusters. The cluster with specific expression in ESC enriches the largest number of lncRNAs. Investigation of lncRNA-protein interaction network revealed that they are not only controlled by classic key transcription factors, but also modulated by epigenetic and epitranscriptomic factors including N6-methyladenosine (m6A) effector machineries.

2022-03-01 | GSE197205 | GEO

Chromatin footprints after double-hit stress

Project description:It was our goal to discern the epigenomic signatures of the ventral hippocampus, in male and female mice in a double hit model of acute stress: one hit of acute restraint stress followed by forced swim stress one week later.

2022-06-20 | GSE200670 | GEO

Chromatin footprints after double-hit stress

Project description:Chromatin footprints after double-hit stress

| PRJNA825824 | ENA

Dynamic lncRNA expression pattern during ESC-derived cardiac differentiation

Project description:Dynamic lncRNA expression pattern during ESC-derived cardiac differentiation

| PRJNA809358 | ENA

Population RNA-seq of human ESC-derived cardiac derivatives

Project description:Population RNA-seq of human ESC-derived cardiac derivatives

| PRJEB30993 | ENA